Peng Li, MD, PhD

Associate Professor (Clinical), University of Utah School of Medicine

Specialties

• Hematopathology
• Molecular pathology

Education

• Doctorate Degree–Molecular Pharmacology and Structural Biology, Thomas Jefferson University
• Medical Degree–Peking University Health Science Center
• Residency–Anatomic and Clinical Pathology, University of Utah School of Medicine
• Fellowship–Hematopathology, Stanford University
• Fellowship–Molecular Genetic Pathology, Baylor College of Medicine

Certification/Affiliations

• American Board of Pathology (Anatomic and Clinical Pathology, Molecular Genetic Pathology, Hematophathology)

Research Interests

• Genetic aspects of myeloid and lymphoid malignancies
• Myeloid neoplasms with germline predisposition

Recent Publications

• Li P, Shahmarvand N, Lynch D, et al. Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist.  Int J Lab Hematol. 2019;41(3):345-352.
• Trobaugh-Lotrario AD, López-Terrada D, Li P, et al. Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer. 2018;65(8):e27103.
• Li P, Wuthrick E, Rappaport JA, et al. GUCY2C signaling opposes the acute radiation-induced GI syndrome. Cancer Res. 2017;77(18):5095­-5106.
• Li P, Lin JE, Snook AE, et al. ST-producing E. coli oppose carcinogen-induced colorectal tumorigenesis in mice. Toxins (Basel). 2017;9(9):279.